Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies To 2035 provides the strategists, marketers and senior management with the critical information they need to assess the global animal testing and non-animal alternative testing market.
Description: Where is the largest and fastest growing market for the animal testing and non-animal alternative testing market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global animal testing and non-animal alternative testing market report to 2035 report answers all these questions and many more.
The report covers the following chapters
•Executive Summary – The executive summary section of the report gives a brief overview and summary of the report. •Report Structure – This section gives the structure of the report and the information covered in the various sections. •Introduction – This section gives the segmentation of the animal testing and non-animal alternative testing market by geography and by type covered in this report. •Market Characteristics – This section introduces the market and provides information on market definitions of animal testing and non-animal alternative testing markets. •Market Value Chain Analysis - This section gives information on value chain analysis for the animal testing and non-animal alternative testing markets. •Non-Animal Alternative Testing Trends – This chapter describes the major trends shaping the global non-animal alternative testing market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities. •Cost Analysis For Animal Testing and Alternative Technologies – This section describes the comparative cost analysis for animal testing and alternative methods to understand the cost-effectiveness and time efficiency of alternative methods. It includes the average cost of animal species and the cost of alternatives to conventional animal testing methods. •Animal Testing And Non-Animal Alternative Testing By Type And End Use – This section describes the overview of the types of non-animal alternative testing technologies. It also highlights the major developers and end-use industries in non-animal alternative testing technologies in the major geographies. •End-User Industries Adoption To Alternative Technologies – This section details information on the adoption of alternative technologies by top end-use industries in the USA, Germany, France, UK, and Japan. This section also includes the adoption of 3R principles by each of the top industries in the USA, China, and Europe. •Global Animal Testing Market Size – This section provides information on the global animal testing market by value and volume for the current and forecast period (2019-2035) and the drivers and restraints that support and restrain the growth of the market during this period. •Global Non-Animal Alternative Testing Market Size – This section provides information on the global non-animal alternative testing market size for the current and forecast period (2019-2035) and the drivers and restraints that support and restrain the growth of the market during this period. •Animal Testing And Non Animal Testing Market Regional And Country Analysis – This section contains the animal testing market by value and volume, and non-animal alternative testing market by value for the major geographies for the current and forecast period (2019-2035). This section also provides end-use industries segmentation in animal alternative testing in the major geographies. •Animal Testing Regulatory Landscape – This section describes the regulatory landscape for animal testing and its alternatives in major geographies. It includes information on regulatory agencies and policies governing animal testing. This section also includes the proposed regulations and guidelines that are driving the non-animal alternative testing technologies market in major geographies. •Competitive Landscape For Alternative Technologies – This section briefs information on major companies involved in the alternative technology market in the USA, China, and Europe. This section includes the profiles of the major alternative technology developers with information on their product portfolio, financial analysis, and strategies implemented by these companies. •Conclusions & Recommendations – Conclusions drawn from the market study are provided in this section. Further, recommendations on the promotion of alternative testing products, the place for demand, the scope for collaborations requirement, and others are also described in this section. •Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered: By Type Of End Use Industrial Application: Pharmaceuticals; Academic Research; Medical Devices; Chemicals & Pesticides; Cosmetics; Others
Countries: China, Japan, Australia, USA, UK, Germany, France. Regions: Asia Pacific, Europe, North America, and Rest of The World
Time series: Seven years forecast and eleven year further forecast.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase • Outperform competitors using accurate up to date demand-side dynamics information. • Identify growth segments for investment. • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market. • Create regional and country strategies on the basis of local data and analysis. • Stay abreast of the latest customer and market research findings • Benchmark performance against key competitors. • Develop strategies based on likely future developments. • Utilize the relationships between key data sets for superior strategizing. • Suitable for supporting your internal and external presentations with reliable high quality data and analysis • Gain a global perspective on the development of the market.
Our reports have been used by over 10K customers, including:
The artificial intelligence in life sciences market was valued at USD 1,101.1 million in 2019, and it is estimated to be worth USD 4,893.1 million by 2025, registering a CAGR of 29.42% during the forecast period (2020 - 2025). Most industries, including life sciences, are witnessing a transformation, owing to increasing cost pressure, a greater...
Alpha L-Iduronidase - Pipeline Review, H2 2020 Summary Alpha L-Iduronidase (IDUA or EC 184.108.40.206) - Alpha L-iduronidase is an enzyme encoded by IDUA gene. It hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. Mutations in this gene...
The government funding for the development of regenerative medicine has been increasing in most developed countries, because of its applications in organ transplantation, tissue engineering, and various other applications. In the United States, two major government agencies, National Institutes of Health (NIH) and California Institute of Regenerative...
251 pages •
By Asia Market Information & Development Company
• Sep 2020
China’s demand for Mental Illness Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer...
193 pages •
By Asia Market Information & Development Company
• Sep 2020
China’s demand for Smoking Cessation Aids has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer...
The North American Chronic Cough market is projected to reach US$ 3,944.89 million by 2027 from US$ 2,118.42 million in 2019; it is estimated to grow with a CAGR of 8.1% from 2020 to 2027. The growth of the chronic cough market is primarily attributed to rising incidences of chronic cough, growing product developments to treat chronic cough....
Seborrhea - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Seborrhea - Pipeline Review, H2 2020, provides an overview of the Seborrhea (Dermatology) pipeline landscape. Seborrhea is form of skin eczema that mainly affects scalp, ears, face,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.